Branning Todd P. 4
4 · NeuBase Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Branning Todd P.
Chief Financial Officer
Transactions
- Award
Common stock
2023-03-16+54,200→ 84,200 total
Footnotes (1)
- [F1]Restricted stock units to be settled by the issuance of one share of common stock for each restricted stock unit that is earned; 25% of which shall vest on March 16, 2024 and the remainder of which shall vest monthly thereafter until March 16, 2027, provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive. Restricted stock units are subject to accelerated vesting, subject to certain conditions, in the event of a change of control of the Issuer.